Yuvraj

Curie-Cancer and Harmonic Pharma sign a partnership agreement for exploring the anti-cancer activity of several compounds

Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities and Harmonic Pharma, which is developing solutions for extending the therapeutic application...

Merck Resolves Previously Disclosed Missouri Consumer Class Action Lawsuit Related to Vioxx

Merck, known as MSD outside the United States and Canada, today confirmed terms of an agreement with plaintiffs to resolve Plubell v. Merck,...

Boehringer Ingelheim presents robust pipeline highlighting its Respiratory R&D

At its 3rd International Research & Development press conference, Boehringer Ingelheim unveiled a pipeline of unique asthma, chronic obstructive pulmonary disease (COPD), idiopathic...

Genzyme Announces Publication of LEMTRADATM (alemtuzumab) Pivotal Studies in The Lancet

Genzyme, aSanofi company , announced today the publication of results from the LEMTRADA™ (alemtuzumab) CARE-MS I and CARE-MS II pivotal studies in patients...

Novartis to start construction of new biotechnology facility in Singapore

Novartis announced the construction of a new state-of-the-art biotechnology production site in Singapore with an investment valued at over USD 500 million. ...

Ariana(R) Pharma and CTCLS sign Japanese distribution agreement for data analysis technology

Ariana Pharma, the premium provider of advanced, non-statistical clinical data and biomarker analytics technology across life science industries as well as the FDA, today...

Adocia announces the strong growth of its turnover

Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines with already approved therapeutic proteins, announces today revenues for the third...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read